MFN Partners’s Korsana Biosciences KRSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-24,209
Closed -$437K – 12
2024
Q3
$437K Hold
24,209
– – 0.01% 12
2024
Q2
$386K Hold
24,209
– – 0.01% 10
2024
Q1
$542K Hold
24,209
– – 0.02% 10
2023
Q4
$568K Hold
24,209
– – 0.02% 12
2023
Q3
$576K Hold
24,209
– – 0.02% 13
2023
Q2
$696K Hold
24,209
– – 0.02% 14
2023
Q1
$1.47M Hold
24,209
– – 0.07% 15
2022
Q4
$2.22M Hold
24,209
– – 0.1% 16
2022
Q3
$2.92M Hold
24,209
– – 0.13% 17
2022
Q2
$1.86M Hold
24,209
– – 0.08% 16
2022
Q1
$3.76M Hold
24,209
– – 0.13% 20
2021
Q4
$5.83M Hold
24,209
– – 0.23% 14
2021
Q3
$10.4M Hold
24,209
– – 0.48% 14
2021
Q2
$13.2M Buy
24,209
+6,868
+40% +$3.01M 0.71% 13
2021
Q1
$6.77M Hold
17,341
– – 0.5% 15
2020
Q4
$7.43M Hold
17,341
– – 0.66% 14
2020
Q3
$14.8M Hold
17,341
– – 1.21% 14
2020
Q2
$14.3M Hold
17,341
– – 2% 9
2020
Q1
$6.43M Buy
17,341
+6,713
+63% +$3.35M 0.85% 13
2019
Q4
$4.05M Hold
10,628
– – 0.83% 10
2019
Q3
$18M Hold
10,628
– – 2.7% 10
2019
Q2
$17M Buy
+10,628
New +$21.1M 2.7% 11

Other funds holding KRSA

MFN Partners's KRSA Position: Q4 2024 in Review

MFN Partners sold out of Korsana Biosciences (KRSA) in Q4 2024, closing a stake of 24,209 shares — an estimated $437K sold.

MFN Partners first reported a position in KRSA in Q2 2019 and held it in 22 quarters. The position peaked at $18M in Q3 2019. 18 funds tracked by Wall St. Rank hold KRSA as of Q4 2024.

  • MFN Partners reported no remaining Korsana Biosciences position as of Q4 2024 after selling out during the quarter.
  • MFN Partners sold 24,209 Korsana Biosciences shares in Q4 2024, an estimated $437K.
  • MFN Partners first reported a position in Korsana Biosciences in Q2 2019 and held it in 22 quarters.
  • MFN Partners's Korsana Biosciences position peaked at $18M in Q3 2019.
  • 18 funds tracked by Wall St. Rank held Korsana Biosciences as of Q4 2024.

Based on MFN Partners's 13F filing for Q4 2024, filed 12 Feb 2025.